SE7714349L - Forfarande for framstellning av hydroxamsyror - Google Patents

Forfarande for framstellning av hydroxamsyror

Info

Publication number
SE7714349L
SE7714349L SE7714349A SE7714349A SE7714349L SE 7714349 L SE7714349 L SE 7714349L SE 7714349 A SE7714349 A SE 7714349A SE 7714349 A SE7714349 A SE 7714349A SE 7714349 L SE7714349 L SE 7714349L
Authority
SE
Sweden
Prior art keywords
procedure
preparation
hydroxamic acids
hydroxamic
acids
Prior art date
Application number
SE7714349A
Other languages
English (en)
Swedish (sv)
Inventor
A H N M Bruins
G Vollema
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of SE7714349L publication Critical patent/SE7714349L/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7714349A 1976-12-18 1977-12-16 Forfarande for framstellning av hydroxamsyror SE7714349L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7614113A NL7614113A (nl) 1976-12-18 1976-12-18 Hydroxamzuren.

Publications (1)

Publication Number Publication Date
SE7714349L true SE7714349L (sv) 1978-06-19

Family

ID=19827406

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714349A SE7714349L (sv) 1976-12-18 1977-12-16 Forfarande for framstellning av hydroxamsyror

Country Status (20)

Country Link
US (1) US4188338A (fi)
JP (1) JPS5384938A (fi)
AR (1) AR218279A1 (fi)
AT (1) AT351016B (fi)
AU (1) AU508902B2 (fi)
BE (1) BE861947A (fi)
CA (1) CA1095532A (fi)
DE (1) DE2756216A1 (fi)
DK (1) DK562277A (fi)
ES (1) ES465157A1 (fi)
FI (1) FI773801A (fi)
FR (1) FR2374301A1 (fi)
GB (1) GB1560176A (fi)
HU (1) HU176050B (fi)
IE (1) IE46006B1 (fi)
LU (1) LU78706A1 (fi)
NL (1) NL7614113A (fi)
PT (1) PT67390B (fi)
SE (1) SE7714349L (fi)
ZA (1) ZA777275B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497827A (en) * 1982-08-30 1985-02-05 Syntex (U.S.A.) Inc. Arachidonic acid analogues as anti-inflammatory and anti-allergic agents
US4792560A (en) * 1985-04-03 1988-12-20 Rorer Pharmaceutical Corporation Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
US5036157A (en) * 1986-03-11 1991-07-30 Burroughs Wellcome Co. Aryl derivatives
US4906667A (en) * 1986-07-30 1990-03-06 E. R. Squibb & Sons, Inc. Phenyl hydroxamic acids including a hetero-containing substituent
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids
US4820828A (en) * 1987-03-04 1989-04-11 Ortho Pharmaceutical Corporation Cinnamohydroxamic acids
US4983567A (en) * 1987-03-16 1991-01-08 Biomeasure, Inc. Immunomodulators and methods of making same
US5804601A (en) * 1995-04-10 1998-09-08 Takeda Chemical Industries, Ltd. Aromatic hydroxamic acid compounds, their production and use
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
AU2003243272A1 (en) * 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
EP1567142A4 (en) * 2002-11-20 2005-12-14 Errant Gene Therapeutics Llc TREATMENT OF PULMONARY CELLS WITH HISTONE DEACETYLASE INHIBITORS
US7098241B2 (en) 2002-12-16 2006-08-29 Hoffmann-La Roche Inc. Thiophene hydroxamic acid derivatives
EP1817020A4 (en) * 2004-11-08 2012-11-21 Errant Gene Therapeutics Inc INHIBITORS OF HISTONATE ACETYLASE
US8022249B2 (en) * 2005-04-01 2011-09-20 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6406688A (fi) * 1964-06-05 1965-12-06
BE689347A (fi) * 1965-12-09 1967-04-14 Madan Ag
GB1171670A (en) * 1967-11-15 1969-11-26 Bdh Chemicals Ltd Derivatives of 4-Aryl-3-Hydroxybutyric Acid
US3600437A (en) * 1969-05-28 1971-08-17 Lilly Co Eli Substituted phenylalkanoic acids and derivatives thereof
US3890377A (en) * 1968-08-15 1975-06-17 Lilly Co Eli 3-Substituted phenylalkanohydroxamic acids
GB1437783A (en) * 1972-09-22 1976-06-03 Boots Co Ltd 2-substituted biphenylyl acetic acids and derivatives thereof

Also Published As

Publication number Publication date
ZA777275B (en) 1978-09-27
IE46006B1 (en) 1983-01-26
PT67390B (en) 1979-05-18
AR218279A1 (es) 1980-05-30
DE2756216A1 (de) 1978-06-22
GB1560176A (en) 1980-01-30
ES465157A1 (es) 1978-10-01
US4188338A (en) 1980-02-12
NL7614113A (nl) 1978-06-20
JPS5384938A (en) 1978-07-26
FI773801A (fi) 1978-06-19
AT351016B (de) 1979-07-10
AU508902B2 (en) 1980-04-03
LU78706A1 (fi) 1978-04-17
PT67390A (en) 1978-01-01
BE861947A (fr) 1978-06-16
DK562277A (da) 1978-06-19
CA1095532A (en) 1981-02-10
AU3140277A (en) 1979-06-14
HU176050B (en) 1980-12-28
FR2374301A1 (fr) 1978-07-13
IE46006L (en) 1978-06-18
ATA892877A (de) 1978-12-15

Similar Documents

Publication Publication Date Title
SE432420B (sv) Forfarande for framstellning av terapeutiskt verksamma hydroxamsyror
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
TR19755A (tr) Tereftalik asidin hazirlanmasina mahsus usul
SE433208B (sv) Forfarande for framstellning av fenoletrar
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE7714349L (sv) Forfarande for framstellning av hydroxamsyror
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO772962L (no) Fremgangsmaate til fremstilling av acylerte heterosyklylkarboksylsyrer
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE421787B (sv) Forfarande for framstellning av kvadratsyra
NO773622L (no) Fremgangsmaate til fremstilling av tereftalsyre
SE399252B (sv) Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE434743B (sv) Forfarande for framstellning av (2-pyrimidinyl-tio)-alkansyraamider
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika